Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1377.989
  • -61.508-4.27%
Close Dec 18 16:00 ET
1443.594High1374.998Low
Constituent Stocks: 10Top Rising: APLS-1.48%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
APLSApellis Pharmaceuticals
34.020-0.510-1.48%1.69M58.56M34.53034.53035.70533.7304.23B2.87B124.39M84.36M+0.06%-0.32%+17.35%+10.63%-11.31%-38.10%-43.17%--2.01%LossLoss5.72%Biotechnology
AAgilent Technologies
133.010-3.450-2.53%1.75M235.03M136.950136.460137.570132.91037.93B37.79B285.19M284.11M-5.79%-5.13%+5.82%-6.10%+2.96%-3.09%-3.84%0.71%0.62%30.0230.023.42%Diagnostics & Research
VRTXVertex Pharmaceuticals
447.500-21.740-4.63%1.76M801.20M467.060469.240471.050445.870115.24B114.91B257.53M256.79M-4.44%-3.55%-0.11%-3.35%-4.53%+11.81%+9.98%--0.69%Loss32.225.37%Biotechnology
BLUEbluebird bio
8.410-0.560-6.24%780.17K6.99M9.1708.9709.7508.02081.76M81.38M9.72M9.68M+7.38%-42.89%+37.82%-15.90%-57.27%-68.14%-69.53%--8.06%LossLoss19.29%Biotechnology
BEAMBeam Therapeutics
26.450-2.130-7.45%1.77M48.11M28.98028.58029.09025.7002.19B1.82B82.81M68.63M-8.48%+1.65%+4.59%+6.78%+12.89%-4.27%-2.83%--2.57%LossLoss11.86%Biotechnology
CRSPCRISPR Therapeutics
41.060-3.570-8.00%2.38M100.63M44.84044.63044.99040.6103.50B3.45B85.35M83.95M-14.06%-19.71%-12.58%-12.25%-23.98%-32.48%-34.41%--2.83%LossLoss9.81%Biotechnology
CRBUCaribou Biosciences
1.780-0.160-8.25%1.82M3.31M1.9501.9401.9501.740161.18M145.21M90.55M81.58M-11.88%-12.53%-10.55%-7.29%+8.54%-69.73%-68.94%--2.24%LossLoss10.83%Biotechnology
NTLAIntellia Therapeutics
12.020-1.110-8.45%3.21M40.02M13.15013.13013.20011.9001.22B1.21B101.85M100.57M-14.75%-17.05%-14.93%-44.01%-46.29%-59.42%-60.58%--3.19%LossLoss9.90%Biotechnology
EDITEditas Medicine
1.345-0.175-11.51%3.13M4.46M1.5201.5201.5201.330111.03M104.00M82.55M77.32M-32.41%-32.41%-45.77%-61.90%-71.20%-86.83%-86.72%--4.05%LossLoss12.50%Biotechnology
SGMOSangamo Therapeutics
2.350-0.470-16.67%9.98M25.13M2.8002.8202.8102.300490.32M479.49M208.65M204.04M+21.13%+21.13%+19.90%+153.72%+555.87%+548.45%+332.54%--4.89%LossLoss18.09%Biotechnology

Comments

Read more